Banaszek A, Bumm TGP, Nowotny B, Geis M, Jacob K, Woelfl M, Trebing J, Kucka K, Kouhestani D, Gogishvili T, Krenz B, Lutz J, Rasche L, Hoenemann D, Neuweiler H, Heiby JC, Bargou RC, Wajant H, Einsele H, Riethmueller G, Stuhler G (2019)
Publication Type: Journal article
Publication year: 2019
Book Volume: 10
Article Number: 5387
Journal Issue: 1
DOI: 10.1038/s41467-019-13196-0
T cell-engaging immunotherapies are changing the landscape of current cancer care. However, suitable target antigens are scarce, restricting these strategies to very few tumor types. Here, we report on a T cell-engaging antibody derivative that comes in two complementary halves and addresses antigen combinations instead of single molecules. Each half, now coined hemibody, contains an antigen-specific single-chain variable fragment (scFv) fused to either the variable light (V
APA:
Banaszek, A., Bumm, T.G.P., Nowotny, B., Geis, M., Jacob, K., Woelfl, M.,... Stuhler, G. (2019). On-target restoration of a split T cell-engaging antibody for precision immunotherapy. Nature Communications, 10(1). https://doi.org/10.1038/s41467-019-13196-0
MLA:
Banaszek, Agnes, et al. "On-target restoration of a split T cell-engaging antibody for precision immunotherapy." Nature Communications 10.1 (2019).
BibTeX: Download